CSL Behring, has entered  into a deal to buy Calimmune Inc. for $91 million. The deal also includes the potential for Calimmune to earn additional performance based milestone payments of up to $325 million over a period currently anticipated to be around eight years or more following the closing of the transaction. The transaction is expected to close within the next two weeks.Continue reading→

The Arizona Bioindustry Association will honor NuvOx Pharma with an AZBio Fast Lane Award at the 2017 AZBio Awards.  Continue reading→

The center will use the money to accelerate development of a Valley fever vaccine for dogs that one day may lead to a successful human vaccine. A California-based biotech company and Colorado State University have joined the center in the effort.Continue reading→

According to Paul Coleman, an Alzheimer’s researcher at the ASU-Banner Neurodegenerative Disease Research Center (NDRC), one of the greatest difficulties plaguing efforts to find effective treatments for Alzheimer’s is the enormous lag between the disease’s inception and the appearance of clinical symptoms.Continue reading→

The Arizona Bioindustry Association will honor Laurence Hurley, PhD, of the University of Arizona College of Pharmacy as the Arizona Bioscience Researcher of the Year at the 2017 AZBio Awards. Arizona life science and business leaders, as well as guests from across the nation, will recognize Dr. Hurley for his legacy of work that has made a significant clinical impact to improve patients’ lives.Continue reading→

Following a national search, the Flinn Foundation board of directors has chosen one of Arizona’s most broadly accomplished executives and community leaders as its new president and chief executive officer.Continue reading→

Avery Therapeutics, bioSyntagma, and Smart Brain Aging  will present at the October conference to feature 32 companies representing the future of healthcare from four states.Continue reading→